Exhibit 107
Calculation of Filing
FORM
(Form Type)
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Class Title (1) |
Fee Calculation Rule |
Amount Registered |
Proposed Maximum |
Maximum |
Fee Rate |
Amount of |
|
$ |
$ |
$ |
$ |
||||
$ |
$ |
$ |
$ |
||||
Total Offering Amounts |
|
$ |
|
$ |
|||
Total Fee Offsets |
|
|
|
||||
Net Fee Due |
|
|
|
$ |
|||
(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional shares of common stock, par value $0.001 per share (the “Common Stock”) of Ultragenyx Pharmaceutical Inc. (the “Registrant”) that become issuable under the Ultragenyx Pharmaceutical Inc. 2023 Incentive Plan (as amended, the “2023 Plan”) and the Ultragenyx Pharmaceutical Inc. Employment Inducement Plan (as amended, the “Inducement Plan” and together with the 2023 Plan, the “Plans”).
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) of the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on The Nasdaq Global Select Market, on July 15, 2025.
(3) Represents 3,000,000 shares of Common Stock authorized for issuance under the 2023 Plan and 500,000 shares of Common Stock authorized for issuance under the Inducement Plan.